NCT05091567 2026-03-10IMforteHoffmann-La RochePhase 3 Active not recruiting660 enrolled 23 charts 1 FDA
NCT02454972 2023-03-02Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid TumorsPharmaMarPhase 2 Completed345 enrolled 34 charts 2 FDA